Their results show a statistically significant reduction in somatic mosaicism in the liver, cerebellum, cortex, hippocampus, olfactory bulb, striatum, and thalamus of Msh2−/− HD mice compared to HD transgenic mice [35]. This evidence concerns the gene MSH2 and Huntington disease.